Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Oct 13, 2026

PMN — ProMIS Neurosciences, Inc. Dilution Risk Tracker

Track PMN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PMN — Get alerts when the score changes →

As of October 13, 2026, ProMIS Neurosciences, Inc. (PMN) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. ProMIS Neurosciences, Inc. has a market capitalization of $84.74M, 8.97M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 9.34M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
25
📊 Float Risk
60
⚠️ Warrant Exposure
90
🔄 Convertible Debt
35

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 34%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 104% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 15%
• Convertible debt present: 8.2% potential dilution
🔔 Track PMN — Get forecast alerts →

Market Data

Market Cap$84.74M
Shares Outstanding8.97M
Float4.60M
Cash$53.46M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore56/100DilutionWatch score record
Shares Outstanding8.97MVerified float table or market cache
Public Float4.60MVerified float table or market cache
Market Cap$84.74MMarket data cache
Cash Runway21.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants9.34MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 100.0% shares (2025Q4 vs prior)
1 institutional holders · 1.7K shares
#1 BANK OF AMERICA CORP /DE/ 1.7K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest238.6K
Days to Cover7.1
% of Float5.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2023-03-08
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PMN Dilution Snapshot

ProMIS Neurosciences, Inc. (PMN) has a DilutionScore of 56/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PMN's DilutionScore is currently 56/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 46/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202656/100HIGH13 days
Aug 22 – Sep 30, 202646/100MEDIUM40 days
Aug 14 – Aug 21, 202645/100MEDIUM7 days
Jul 16 – Aug 13, 202653/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PMN shares outstanding have increased 316.6% from 2.15M (Mar 2026) to 8.97M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 20268.97M4.60M▲ 0.02%
Mar 31, 20268.97M4.60M▲ 316.64%
Mar 30, 20268.97M1.11M▼ 13.14%
Mar 09, 20262.15M1.27M▼ 0.11%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PMN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PMN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PMN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PMN
PMN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.